Novo Nordisk

$69.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.66 (-0.94%) Today
$0.00 (0.00%) As of 8:01 PM UTC after-hours

Why Robinhood?

You can buy or sell Novo Nordisk and other stocks, options, and ETFs commission-free!

About NVO

Novo-Nordisk A/S, also called Novo Nordisk, is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals.

CEO
Lars Fruergaard Jørgensen
Employees
45,323
Headquarters
Bagsværd, Capital Region
Founded
1925
Market Cap
161.17B
Price-Earnings Ratio
25.40
Dividend Yield
1.47
Average Volume
839.94K
High Today
$69.73
Low Today
$69.30
Open Price
$69.52
Volume
573.66K
52 Week High
$75.86
52 Week Low
$58.36

NVO Earnings

$0.00
$0.25
$0.51
$0.76
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available May 5, Pre-Market

You May Also Like

LPG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure